ADC THERAPEUTICS SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.34 USD | -2.25% |
|
-8.05% | +161.45% |
| 04-09 | Transcript : ADC Therapeutics SA - Special Call | |
| 04-04 | Sector Update: Health Care Stocks Slump Late Afternoon | MT |
Chart calendar ADC Therapeutics SA
315.ooNPk78CGIZXsRBz4GrkFcjbhuuUZxJ_-pD0txIbicA.8_o6pohGaugR8mM3hS6zIfC00NmjJV0tvNS94Gt_v7jE0Sij-UxJviOHJA~0b092b4f182ffba246d3ece6cfe1bfae
Upcoming events on ADC Therapeutics SA
Past events on ADC Therapeutics SA
| 09/04/2024 23:05 | American Association for Cancer Research Meeting - Abstract No: 6573 |
| 09/04/2024 21:00 | Investor Meeting |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract No: 5085 |
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract No: 3122 |
| 08/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract No: CT059 |
| 07/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract No: LB022 |
| 07/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract No: 875 |
| 13/03/2024 12:30 | Q4 2023 Earnings Call |
| 13/03/2024 11:00 | Q4 2023 Earnings Release |
| 12/03/2024 13:30 | Guggenheim Healthy Altitudes Summit |
| 05/03/2024 14:50 | TD Cowen Health Care Conference |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract: 4469 |
| 12/12/2023 01:45 | American Society of Hematology Meeting - Abstract: 984 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract: 3133 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract: 3097 |
| 14/11/2023 10:00 | Jefferies London Healthcare Conference |
| 07/11/2023 13:30 | Q3 2023 Earnings Call |
| 07/11/2023 12:00 | Q3 2023 Earnings Release |
| 04/10/2023 14:45 | RBC Antibody Drug Conjugate Day |
| 27/09/2023 21:45 | Cantor Global Healthcare Conference - Fireside Chat |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,34 | 0,00 1,03 - | 33,9 33,0 2.77% | 210 204 2.8% | 69,6 68,3 1.9% | 80,9 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -179 -199 9.92% | -199 -245 19.1% | -72,0 -95,0 24.26% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -219 -197 -11.52% | -262 -258 -1.29% | -124 -130 4.84% | -166 -169 1.93% | -158 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -246 -241 -2.21% | -252 -263 4.36% | -155 -152 -2.02% | -195 -203 3.88% | -176 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -246 -243 -1.27% | -230 -264 13.01% | -156 -149 -4.68% | -240 -196 -22.23% | -183 |
|
EPS USD | Released Forecast Spread | -2,36 | -3,77 -3,53 -6.86% | -3,00 -3,36 10.78% | -1,99 -1,90 -4.46% | -2,94 -2,39 -22.81% | -2,15 |
| Announcement Date | 24/04/20 | 18/03/21 | 03/03/22 | 28/02/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17,0 16,5 3.3% | 46,5 37,1 25.28% | 17,3 31,2 -44.62% | 76,3 47,0 62.36% | 69,8 65,5 6.58% | 19,0 20,1 -5.47% | 19,3 20,1 -3.95% | 14,5 15,2 -4.39% | 16,8 15,3 10.02% | 18,3 | 19,4 | 20,4 | 20,8 |
|
EBITDA Million USD | Released Forecast Spread | -15,5 -77,1 79.91% | ||||||||||||
|
EBIT Million USD | Released Forecast Spread | -62,8 -64,1 2.02% | -40,4 -48,2 16.25% | -69,4 -60,2 -15.25% | -3,11 -43,3 92.81% | -10,7 -19,4 44.69% | -51,6 -59,9 13.94% | -39,8 -40,2 1.11% | -37,4 -45,3 17.36% | -40,0 -40,4 1.14% | -40,0 | -39,6 | -39,4 | -39,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -56,4 -60,8 7.3% | -17,8 -52,7 66.16% | -65,3 -72,6 10.09% | -51,3 -52,5 2.31% | -20,2 -23,9 15.36% | -59,7 -47,5 -25.6% | -53,7 -46,2 -16.19% | -47,9 -52,3 8.5% | -39,9 -42,1 5.32% | -45,1 | -44,9 | -44,7 | -44,9 |
|
Net income Million USD | Released Forecast Spread | -34,4 -64,6 46.79% | -16,7 -49,0 65.98% | -64,4 -62,3 -3.3% | -50,6 -44,7 -13.24% | -24,2 -17,5 -38% | -59,4 -49,9 -19.07% | -47,1 -46,6 -1.02% | -47,8 -52,0 8.02% | -85,0 -42,1 -101.91% | -47,5 | -47,3 | -46,7 | -46,9 |
|
EPS USD | Released Forecast Spread | -0,45 -0,85 46.79% | -0,22 -0,67 67.33% | -0,84 -0,81 -4.22% | -0,65 -0,57 -13.64% | -0,30 -0,21 -43.18% | -0,74 -0,64 -15.64% | -0,58 -0,57 -1.75% | -0,58 -0,63 8.46% | -1,03 -0,50 -105.18% | -0,57 | -0,57 | -0,54 | -0,52 |
| Announcement Date | 03/03/22 | 09/05/22 | 09/08/22 | 08/11/22 | 28/02/23 | 09/05/23 | 08/08/23 | 07/11/23 | 13/03/24 | - | - | - | - |
More events
Past sector events for ADC Therapeutics SA
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ADCT Stock
- Calendar ADC Therapeutics SA
